期刊文献+

sTfR与孕妇、新生儿、婴儿亚临床缺铁及缺铁性贫血前瞻性纵向研究 被引量:5

Forward-looking longitudinal study about sTfR with pregnant women,neonatal,infant's subclinical iron deficiency and iron deficiency anemia
原文传递
导出
摘要 【目的】通过前瞻性纵向监测贫血孕妇及其新生儿、婴儿的Hb,sTfR,分析孕妇贫血对婴儿6月龄时铁代谢的影响。【方法】随机抽取Hb<100 g/L的56例临产孕妇作为研究组,选取56例Hb>110 g/L的同孕周临产孕妇作为对照组,两组孕妇所生各56例新生儿、婴儿为子代研究组、子代对照组,婴儿于出生时、42 d、4个月、6个月进行定期体检,孕妇、新生儿、6月龄婴儿抽血检测Hb、sTfR。【结果】与对照组比较,贫血孕妇及其所生婴儿6月龄时的Hb、sTfR值差异有统计学意义(P<0.01),新生儿Hb、sTfR值差异无统计学意义(P>0.05)。贫血孕妇所生婴儿6月龄时IDA检出率为60.8%%,正常孕妇所生婴儿为21.6%,差异有统计学意义(P<0.01)。【结论】孕妇贫血是导致6月龄婴儿SID及IDA的主要危险因素。 [Objective] Through the forward looking longitudinal monitoring anemia pregnant women and neonatal, infant's Hb, sTfR, to analysis the influence of iron metabolism of 6 months infant when pregnant women suffering from a- nemia. [Methods] Randomly selected 56 cases parturient women which Hb 〈100 g/L as study group, another 56 cases parturient women with gestational age at birth which Hb 〉110 g/L as control group. Their neonates were divided into two groups: progeny study group and progeny control group. Babies were regular check-up at birth, 42^nd day, 4^th month, 6^th month. All of them were extracted blood testing Hb, sTfR. [Results] Compared with controls, the pregnant women and 6 months old babies' Hb and sTfR value had very significant differences(P〈0.01) . Neonatal Hb and sTfR value had no significant differences(P〈0. 05). Anemia pregnant women's babies of 6 months old, 60.8% suffered from IDA. The normal pregnant women's babies, only 21.6% suffered from IDA. Difference was very significant(P〈0.01). [Conclusion] Pregnant women anemia is one of risk factors to cause 6^th month infant subclinical iron deficiency and IDA.
出处 《中国儿童保健杂志》 CAS 2011年第9期792-794,共3页 Chinese Journal of Child Health Care
基金 上海市长宁区卫生局科研课题(20090109)
关键词 转铁蛋白受体 亚临床缺铁 缺铁性贫血 serum transferring receptor sTfR subclinical iron deficiency SID iron deficiency anemia IDA
  • 相关文献

参考文献9

二级参考文献40

  • 1陈嘉林,李淑兰,徐闽,王海滨,葛昌文,李蓉生.血清转铁蛋白受体对贫血患者鉴别诊断的临床意义[J].中华内科杂志,2004,43(6):423-425. 被引量:12
  • 2中国儿童铁缺乏症流行病学调查协作组.中国7个月~7岁儿童铁缺乏症流行病学的调查研究[J].中华儿科杂志,2004,42(12):886-891. 被引量:230
  • 3WHO. Issues of communication and risk-world health report 2002. [2008-05-08]. http://www. comminit. com/en/node/212038.
  • 4Lindsay H. What works? A review of the efficacy and effectiveness of nutrition interventions. [2008-05-08]. http://www. unsystem. org/SCN/ archives/npp19/index. htm.
  • 5Strauss MB. Anemia of infancy from maternal iron deficiency in pregnancy. J Clin Invest, 1993,8:345-353.
  • 6Colomer J, Colomer C, Gutierrez D, et al. Anaemia during pregnancy as a risk factor for infant iron deficiency: report from the Valencia Infant Anaemia Cohort (VIAC) study. Paediatr Perinat Epidemiol,1990 ,4 : 196-204.
  • 7Kilbride J, Baker T,Parapia G ,et al. Anaemia during pregnancy as a risk factor for iron deficiency anaemia in infancy: a case-control study in Jordan. Int J Epidemiol, 1999,28 : 461-468.
  • 8De Pee S, Bloem MW, Sail M, et al. The high prevalence of low hemoglobin concentration among Indonesian infants aged 3-5 months is related to maternal anemia. J Nutr, 2002,132:2215-2221.
  • 9Van Rheenan P, Brabin BJ. Late umbilical cord-clamping as an intervention for reducing iron deficiency anaemia in term infants in developing and industrialised countries. Ann Trop Paediatr, 2004,24: 3-16.
  • 10Stanley Z. The role of nutrition in the prevention of iron deficiency anemia in infants, children and adolescents. CMAJ, 2003,168-59-63.

共引文献70

同被引文献55

  • 1鲁然.转铁蛋白受体和铁蛋白在缺铁性贫血诊断中的意义[J].实用医技杂志,2007,14(13):1690-1691. 被引量:7
  • 2王学艳,杨雪飞,张明,何欢,马瑞琴.过敏性皮肤病与食物过敏原特异性免疫球蛋白G的临床分析[J].南方医科大学学报,2006,26(1):15-15. 被引量:31
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8229
  • 4陆再英,钟南山.内科学(第7版)[M].北京:人民卫生出版社,2008,726-728.
  • 5Agarwal R, Aggarwal AN, Gupta D, et al. Inhaled corticoste- roids vs placebo for preventing COPD exacerbations., a systemat- ic review and metaregression of randomized controlled trials[J]. Chest, 2010, 137(2) :318.
  • 6Short AF, Doyle J, Stern L, et al. Anemia in chronic obstruc- tive pulmonary disease: epidemiology and economic implications [J].Curr MedResOpin, 2008, 24(4):1123.
  • 7Barba R, de Casasola GG, Marco J, et al. Anemia in chronic obstructive pulmonary disease: a readmission prognosis factor [J].Curt MedResOpin, 2012, 28(4) :617.
  • 8Theurl I, Schroll A, Nairz M, et al. Pathways for the regula- tion of hepcidin expression in anemia of chronic disease and iron deficiency anemia in vivo[J]. Haematologica, 2011, 96 (12) : 1761.
  • 9Young B, Zaritsky J. Hepcidin for clinicians[J]. Clin J Am Soc Nephrol, 2009, 4(8):1384.
  • 10Pietrangelo A. Hepcidin in human iron disorders: therapeutic implications[J]. J Hepatol, 2011, 54(1) :173.

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部